Voting by mail is at least 200 years old in America, catching up on powerful women in our past, are we going the way of Ancient Rome, and how can we identify the trustworthy.
As the search for a COVID-19 vaccine continues, we also continue to ponder who will be in the front of the queue. If we wish to restore our economy, we must undoubtedly consider vaccinating essential workers early on. But who exactly are they?
New York Governor Andrew Cuomo would rather allow more Americans to become infected with and die from coronavirus than to allow an imperfect vaccine distribution plan to proceed.
Every year Livermore National Laboratory produces a chart of where our energy comes from and where it goes. The biggest changes, less coal, more natural gas.
There's nothing like fear to generate abnormal behavior. And in the age of COVID-19 there's plenty of fear going around (so expect a lot of it). In the past few months, we've seen that one of these odd behaviors is attributed to a significant number of health-news headlines recommending vitamin C to purportedly assist one's immune response to COVID-19. Let's take a closer look.
To reduce payments to doctors by device manufacturers and pharma companies, the federal government instituted a regulatory policy, the Sunshine Act, in 2013. The goal was to allow the disinfecting nature of transparency to reduce the ethical problem of obligation when receiving "gifts." Two reports update how that battle seems to be going.
Pfizer's vaccine is based on RNA, which is a very unstable molecule that is prone to breaking down. Storing it at -94° F prevents this, but it creates the logistical difficulty of transporting the vaccine.
By any measure, today's announcement about the unexpected efficacy of the Pfizer/BioNTech coronavirus vaccine is great news. But, Pfizer's Dr. Robert Popovian cautions us that the job is not done. There are policies that are essential to ensure the vaccine is promoted to the public, distributed, and administered properly. And be priced so that everyone can get it. Devil. Details.
The value of hydroxychloroquine in treating COVID-19 patients continues to rise from the ashes of refutation in the medical literature. The latest iteration is a meta-analysis of utilizing the drug early in ambulatory patients' care to lessen the undesirable outcomes of infection, hospitalization, and death. Several of our readers and members of our Board of Scientific Advisors believe that this study is important and that we disregard it at our risk. We are letting a proponent of each side make their case.
Be honest. Few of us actually read nutritional labels. That said, marketing specialists have studied which labels may make a difference, and to whom. Can we use their findings to help us make other choices?
